Sendurai A. Mani

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

62h-index30.7kcitations283works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(137), Cancer-related molecular mechanisms research(29), FOXO transcription factor regulation(27), Cancer Genomics and Diagnostics(26), Epigenetics and DNA Methylation(25)

Publications283 total

EMT-induced stem cell and mesenchymal programs can be decoupled via cell division and ESRP1-dependent mechanisms
iScience·2025Open Access
Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancer
Cancer Treatment Reviews·2025
Functional plasma cell signatures mark AML chemotherapy responders: Evidence from immune niche profiling
Blood·2025Open Access
Spatially resolved profiling reveals the perifollicular border zone as a key immunologic hub in follicular lymphoma undergoing mosunetuzumab therapy
Blood·2025Open Access
3119 – DECIPHERING THE AML NICHE: RNA SEQUENCING AND SPATIAL TRANSCRIPTOMICS REVEAL DIVERSE TRANSCRIPTOMIC LANDSCAPES IN RESPONDERS VERSUS NONRESPONDERS
Experimental Hematology·2025
Advancing Cancer Biology: Highlights from the 2025 FASEB SRC on Cellular Plasticity in Cancer
Cancer Heterogeneity and Plasticity·2025Open Access
Mutations in MLL3 promote breast cancer progression via HIF1α-dependent intratumoral recruitment and differentiation of regulatory T cells
Immunity·2025· 5 citedOpen Access
Acquired resistance to molecularly targeted therapies for cancer
Cancer Drug Resistance·2025· 9 citedOpen Access
491 | SPATIAL TRANSCRIPTOMICS OF FOLLICULAR AND MARGINAL ZONE LYMPHOMAS IDENTIFIES DOMAINS OF CD8+ T CELL RECRUITMENT AND EXCLUSION
Hematological Oncology·2025· 1 citedOpen Access
eLife assessment: ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
2025Open Access
β-Catenin Drives the FOXC2-Mediated Epithelial–Mesenchymal Transition and Acquisition of Stem Cell Properties
Cancers·2025· 3 citedOpen Access
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients
Oncotarget·2025· 2 citedOpen Access
Supplementary Data from Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer
2025Open Access
Data from Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer
2025Open Access
Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer
Cancer Research·2025· 1 citedOpen Access
The Cancer Chimera: Impact of Vimentin and Cytokeratin Co-Expression in Hybrid Epithelial/Mesenchymal Cancer Cells on Tumor Plasticity and Metastasis
Cancers·2024· 4 citedOpen Access
eLife Assessment: ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
2024Open Access
Therapeutic insights for the aggressive subset of high-grade gliomas (HGG) driven by chromosome 1q32 <i>MDM4-containing</i> amplicon and unmethylated <i>MGMT</i>.
Journal of Clinical Oncology·2024· 1 cited
Abstract LB225: Regulation of breast cancer stem cell identity by PLK1 and FOXC2
Cancer Research·2024
eLife assessment: STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer
2024Open Access
page 1 of 15Next →

Frequent Co-authors

Robert A. Weinberg(10), Herbert Levine(9), Mohit Kumar Jolly(8), Jing Yang(7), Joseph H. Taube(7), Kurt W. Evans(7), Petra den Hollander(7), Jeffrey M. Rosen(6), Nathalie Sphyris(6), Eshel Ben‐Jacob(5), Steven J. Werden(5), Jeffrey T. Chang(5), Massimo Cristofanilli(5), Wenjun Guo(4), Maryam Shariati(4), Naoyuki Miura(4), Rama Soundararajan(4), Tapasree Roy Sarkar(4), James M. Reuben(4), Michal Mego(4)